The Obama administration won't back repeal of the 2.3% medical device tax contained in the Affordable Care Act, says Health & Human Services Dept. secretary Kathleen Sebelius.
The White House will not support repeal of the medical device tax, Dept. of Health & Human Services Secretary Kathleen Sebelius said during a House hearing this week.
House Rep. Larry Bucshon (R-Ind.) asked Sebelius why the Obama administration continues to oppose repeal of the medtech tax despite "overwhelming support" from Congress. He cited the Senate's bipartisan, non-binding 79-20 vote to repeal the medical device tax as well as last year's House vote as evidence of Congress' willingness to strike the levy.
Efforts to undermine the medical device tax are "narrow-minded and dishonest" attempts to win "special treatment," says an editorial published this week in the LA Times.
Efforts to take down the medical device tax have been repeatedly scrutinized by critics that paint repeal efforts as disingenuous or misguided, most recently in an LA Times editorial calling on the industry to defend its logic.
Seemingly everyone on Capitol Hill wants to repeal the medical device tax, but efforts to target the Patient Protection & Affordable Care Act as a whole may be getting in the way.
Last week, the GOP-controlled House of Representatives cast its 37th vote to repeal, de-fund or dismantle the Patient Protection & Affordable Care Act.
The bill, which passed 229-195 along partisan lines, will do nothing to halt the forward progress of the landmark healthcare reform law and amounted to little more than allowing newly minted Republican lawmakers a chance to keep a campaign promise.
The millions of dollars in fees that medical device companies pay for FDA review aren't exempt from sequestration, meaning the agency may lack the resources to keep up with promises that it made to the industry in exchange for the funds.
The federal sequester is siphoning away part of the funds that the medical device industry is paying for FDA review of new technologies, and that means the agency may not be able to keep all the promises it made in exchange for hiking its user fees.
The New York Times lists the 10 most expensive hospitals in the United States, based on CMS data
MASSDEVICE ON CALL — Bayonne Medical Center in Bayonne, N.J., billed Medicare an average of 4 times higher than the national average for the 100 most common procedures, according to the New York Times.
J.C. Scott, SVP, government affairs for AdvaMed is named one of the top lobbyists in the Beltway by CEO Update, a publication covering trade councils
AdvaMed's government affairs guru J.C. Scott has been named a "top lobbyist" by CEO Update, a publication that covers the trade association industry.
Scott received praised by the publication for his work on efforts to repeal the medical device tax,. He was one of only two healthcare related lobbyists on the list.